by Ursula Tschorn | Apr 6, 2026 | Regulatory
Pharmaceutical import into Germany is governed by a precise regulatory framework that creates both obligations and opportunities for international traders. Whether you are pursuing parallel import, individual import under Article 73.3 AMG, or exploring niche products...
by Ursula Tschorn | Apr 6, 2026 | Drug Dictionaries
German pharma market access data is the foundation of every pricing, reimbursement, and launch decision for pharmaceutical companies entering Europe’s largest single-country drug market. Germany generates over EUR 60 billion in annual pharmaceutical revenue at...
by Ursula Tschorn | Apr 6, 2026 | Drug Dictionaries
A pharmaceutical data API is a programmatic interface that delivers structured drug information — PZN identifiers, pricing, active ingredients, dosage forms, and clinical data — directly into your software. In 2026, with Germany’s electronic patient...
by Ursula Tschorn | Apr 6, 2026 | Regulatory
An eu drug authorization database is a consolidated platform that lets pharmaceutical professionals search marketing authorizations across multiple countries from a single interface. Instead of navigating dozens of national registries in different languages, you query...
by Ursula Tschorn | Apr 6, 2026 | Drug Pricing
German drug pricing data is among the most requested datasets in global market access. Germany is the largest pharmaceutical market in Europe, the fourth-largest worldwide, and serves as a reference price country for around 16 European countries. With statutory health...
